Insiders who reported open-market trades in the last 12 months at the companies Versant Venture Capital VI, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Versant Venture Capital VI, L.P. is an investment firm of LENZ Therapeutics, Inc. (LENZ). InsiderAlpha holds 9 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Versant Venture Capital VI, L.P. last file a Form 4?
The most recent primary Form 4 on record is dated 30 September 2025, one of 9 filings going back to 2024.
Has Versant Venture Capital VI, L.P. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 41 open-market sales ($54.41M) across all tracked filings.
Versant Venture Capital VI, L.P. files SEC Form 4 reports at LENZ Therapeutics, Inc. (LENZ). 9 SEC Form 4 filings on record going back to 2024, most recently on 30 September 2025. Most recent open-market trade: sold $6K of LENZ on 30 September 2025. Lifetime open-market sales: $54.41M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Versant Venture Capital VI, L.P..
InsiderAlpha's records for Versant Venture Capital VI, L.P. go back to 2024: 9 primary Form 4 filings, an average of 3.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
